News & Analysis as of

Social Media › Medical Devices

Follow this channel for insights at the intersection of social media and the law, covering a wide array of issues from employer liability to privacy, from advertising rules to IP matters, and... more +
Follow this channel for insights at the intersection of social media and the law, covering a wide array of issues from employer liability to privacy, from advertising rules to IP matters, and more. Like this! less -
Dechert LLP

Dechert Re:Torts - Key Developments in Product Liability and Mass Torts - Issue 10

Dechert LLP on

Senators Focus Attention on Litigation Funding’s Opacity - Building on the momentum we previously noted related to litigation funding, on September 14, Senator John Kennedy introduced the Protecting Our Courts from Foreign...more

Mitchell, Williams, Selig, Gates & Woodyard,...

New Theories of Product Liability Develop in the Age of Artificial Intelligence and Increased Automation

Mitchell, Williams, Selig, Gates & Woodyard,... on

In recent years, products liability law has been significantly impacted by advancements in technology, particularly with the rise of artificial intelligence (AI) and automation. As more companies adopt these technologies to...more

Mintz - Health Care Viewpoints

The AI Search Engine Doctor Is Always In: What Are the Regulatory and Legal Implications?

Mintz - Health Care Viewpoints on

The information age in which we live is reaching a new milestone with the development and ready access to conversational artificial intelligence based on advanced transformer algorithms, or AI chatbots, including their...more

Hanzo

FDA Regulatory Compliance: Can You Prove What Your Website Said?

Hanzo on

If you’re marketing any pharmaceutical or medical device, the Food and Drug Administration (FDA) has its eye on you. More accurately, the FDA has its eye on your website and social media, checking to see what you’re claiming...more

Akerman LLP - Health Law Rx

Physicians: Beware of FTC Rules for Product Endorsements

Akerman LLP - Health Law Rx on

It has become increasingly common for physicians and other healthcare professionals to share medical information with the public via video platforms, blogs, and social media sites. ...more

Hanzo

How a Multifaceted Lawyer Takes on Multidistrict Litigation

Hanzo on

Sean Burke, Partner at Duane Morris, fills us in on the challenges of multidistrict litigation, the advantages of social media evidence, and new medical device technology. Sean Burke, a partner at Duane Morris LLP,...more

Robinson & Cole LLP

Data Privacy + Cybersecurity Insider - February 2019 #4

Robinson & Cole LLP on

In an effort to phase out what many in the security world believe are threats to the cybersecurity posture of governmental agencies and private entities alike, John Quinn, the Chief Information Officer of the State of...more

Robinson & Cole LLP

Data Privacy + Cybersecurity Insider - October 2018

Robinson & Cole LLP on

On October 1, 2018, the Food and Drug Administration (FDA) issued its “Medical Device Cybersecurity Regional Incident Preparedness and Response Playbook” to address continued threats to medical devices that could affect...more

Knobbe Martens

Social Media Success: Trends in Pharma Digital Strategies

Knobbe Martens on

Information, the majority (73%) of pharmaceutical marketing teams expect to use or continue to use the popular social media forum Facebook to facilitate their digital marketing strategies over the next one to two years....more

Mintz - Health Care Viewpoints

FDA to Study Social Media Promotion

Mintz - Health Care Viewpoints on

On November 7, 2016, FDA announced in the Federal Register its plan to research methods for including risk information about pharmaceutical and medical device products in promotional Internet communications that have...more

Mintz - Health Care Viewpoints

Review of International Regulation of Social Media Promotions at the 2016 RAPS Conference

Mintz - Health Care Viewpoints on

The Regulatory Affairs Professionals Society (RAPS) held its annual Convergence conference last week in San Jose. The event certainly illustrated RAPS’s global influence given that the attendees represented many of the...more

Arnall Golden Gregory LLP

AGG Food & Drug Newsletter - August 2016

Arnall Golden Gregory LLP on

Arnall Golden Gregory LLP's Food and Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community, including regular updates on legislative initiatives from AGG’s Washington, DC...more

Buchalter

Technology Industry Newsletter - October 2015

Buchalter on

We hope you enjoy this edition of our Tech Newsletter. As technology continues to drive business innovation and growth, new and existing companies positioned to take advantage of the tech trends for 2016 will be better...more

Robins Kaplan LLP

PATIENT PRIVACY IN AN ERA OF SOCIAL MEDIA

Robins Kaplan LLP on

The rise of social media has introduced new opportunities and new legal challenges for companies in the health care industry. Attorneys Seth Northrop and Sharon Roberg-Perez discuss the legal issues faced by care providers,...more

Dechert LLP

What’s Next for the FDA’s Draft Social Media Guidances?

Dechert LLP on

As many of our life sciences clients know, 2014 brought long-awaited draft guidance documents from the FDA regarding three social media-related topics of interest. The FDA provided its much-anticipated views on...more

BakerHostetler

FDA Allowing Additional Comment Period for Draft Social Media Guidances

BakerHostetler on

The Food and Drug Administration (FDA) is reopening the comment period for two draft social media guidances in response to requests for additional time to allow interested persons to submit comments. Beginning September 29,...more

Morrison & Foerster LLP

Drugs and the Internet: draft guidance on social media platforms and prescription drugs

Morrison & Foerster LLP on

The Food and Drug Administration (FDA) recently promulgated two much-anticipated draft guidance documents on the use of social media to present information about prescription drugs and medical devices. The draft guidance...more

McDermott Will & Emery

FDA Issues Draft Guidance on Communications Over Internet and Social Media Platforms

McDermott Will & Emery on

On June 17, 2014, the U.S. Food and Drug Administration (FDA or the Agency) issued two draft guidance documents, providing recommendations for two types of communication over internet and social media platforms. The first...more

Akerman LLP - Health Law Rx

FDA Issues Draft Guidance for Drug and Device Information on Social Media

Akerman LLP - Health Law Rx on

On June 17, 2014, the FDA issued two draft guidance documents relating to the use of social media and the Internet to promote prescription drugs and medical devices. The FDA described how a company should use a character...more

Epstein Becker & Green

More of the Same: Recently Released FDA Social Media Guidance for the Life Sciences Industry

Epstein Becker & Green on

On June 17, 2014, the U.S. Food and Drug Administration ("FDA") continued to outline its expectations for pharmaceutical and medical device manufacturer use of social media platforms to promote manufacturers' products in two...more

20 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide